North Run Capital’s Safeguard Scientifics, Inc. SFE Stock Holding History

North Run Capital’s Portfolio SFE Stock Details SFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$861K	Buy	277,728 +450	+0.2%	+$1.51K	1.98%	16
2022 Q3	$1.03M	Sell	277,278 -40,066	-13%	-$161K	2.1%	13
2022 Q2	$1.18M	Sell	317,344 -217,704	-41%	-$910K	2.43%	13
2022 Q1	$2.79M	Sell	535,048 -355,352	-40%	-$2.15M	4.11%	11
2021 Q4	$6.54M	Sell	890,400 -5,578	-0.6%	-$43.6K	5.03%	9
2021 Q3	$7.96M	Buy	895,978 +50,286	+6%	+$403K	5.74%	9
2021 Q2	$6.56M	Buy	+845,692	New	+$5.77M	4.47%	11

Other funds holding SFE

CCM

Contrarian Capital Management Greenwich, Connecticut $357M AUM 18.27% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ZCA

Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

North Run Capital's SFE Position: Q4 2022 in Review

North Run Capital increased its Safeguard Scientifics, Inc. (SFE) stake by 0.16% in Q4 2022, buying an estimated $1.51K and bringing the position to 277,728 shares worth $861K. The position accounts for 1.98% of the portfolio, ranked #16.

North Run Capital first reported a position in SFE in Q2 2021 and has held it in 7 quarters since. The position peaked at $7.96M in Q3 2021. 44 funds tracked by Wall St. Rank hold SFE as of Q4 2022.

North Run Capital held 277,728 shares of Safeguard Scientifics, Inc. worth $861K as of Q4 2022.
North Run Capital bought 450 Safeguard Scientifics, Inc. shares in Q4 2022, an estimated $1.51K.
Safeguard Scientifics, Inc. made up 1.98% of North Run Capital's portfolio in Q4 2022, its #16 holding.
North Run Capital first reported a position in Safeguard Scientifics, Inc. in Q2 2021 and has held it in 7 quarters since.
North Run Capital's Safeguard Scientifics, Inc. position peaked at $7.96M in Q3 2021.
44 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q4 2022.

Based on North Run Capital's 13F filing for Q4 2022, filed 14 Feb 2023.